| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |